31.10.2022, 13:18

SPH Individual financial report according to IFRS as at 30 September 2022

Individual financial report according to IFRS as at 30 September 2022

Data	Tytuł	Kurs	Zmiana
2023-01-30	SPH Individual financial report according to IFRS as at 31 December 2022	10,40	-5,28
2023-01-27	SPH "Sopharma" AD submitted for approval to the Financial Supervision Commission for an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD	10,42	-0,19
2023-01-20	SPH Publication of the Tender offering addressed to the shareholders of âSopharmaâ AD by âDonev Investments Holdingâ AD and Opinion of the Board of Directors in connection with Art. 154 of the Law on Public Offering of Securities and Art. 36 of Ordinance 13 of 22.12.2003 on tender offerings for purchase and exchange of shares	10,40	0,00
2023-01-13	SPH Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD	10,30	0,00
2023-01-12	SPH Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 11 January 2023.	9,80	+1,02
2023-01-11	SPH Sales revenues for December 2022	9,80	0,00
2023-01-03	SPH Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2022.	10,40	-0,96
2023-01-03	SPH zbycie akcji przez podmiot powiÄzany	10,40	-0,96
2022-12-22	SPH Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.	9,65	0,00
2022-12-22	SPH Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.	9,65	0,00